ID   MZ93
AC   CVCL_F999
DR   TKG; TKG 0712
DR   Wikidata; Q54907271
RX   PubMed=11792418;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11792418).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0712
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
RX   PubMed=11792418; DOI=10.1016/S0145-2126(01)00115-1;
RA   Hashimoto S., Toba K., Tsuchiyama J., Abe T., Yano T., Momoi A.,
RA   Okazuka K., Kanazawa N., Takahashi M., Aizawa Y.;
RT   "CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid
RT   antigens.";
RL   Leuk. Res. 26:289-295(2002).
//